A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2019; you can also visit the original URL.
The file type is application/pdf.
The Potential of Alkaline Phosphatase as a Treatment for Sepsis-Associated Acute Kidney Injury
2014
Nephron Clinical Practice
Preserved Fulltext
stress, which can be converted by alkaline phosphatase into the tissue-protective and anti-inflammatory molecule adenosine. Human recombinant alkaline phosphatase, a recently developed replacement for bovine-derived alkaline phosphatase, has shown promising results in the preclinical phase. As its safety and tolerability were recently confirmed in a phase I clinical trial, the renal protective effect of human recombinant alkaline phosphatase in sepsis-associated AKI shall be investigated in a
doi:10.1159/000363256
pmid:25343839
fatcat:to6cz3mchne4lo2nxqiqqvs2vi